TCMBANKGE000881 |
PLAT |
T-PA; TPA |
plasminogen activator, tissue type |
TCMBANKGE001079 |
CYP1A1 |
AHH; AHRR; CP11; CYP1; CYPIA1; P1-450; P450-C; P450DX |
cytochrome P450 family 1 subfamily A member 1 |
TCMBANKGE000742 |
SMAD7 |
CRCS3; MADH7; MADH8 |
SMAD family member 7 |
TCMBANKGE000045 |
IRS2 |
IRS-2 |
insulin receptor substrate 2 |
TCMBANKGE000567 |
CDKN2A |
ARF; CDK4I; CDKN2; CMM2; INK4; INK4A; MLM; MTS-1; MTS1; P14; P14ARF; P16; P16-INK4A; P16INK4; P16INK4A; P19; P19ARF; TP16 |
cyclin dependent kinase inhibitor 2A |
TCMBANKGE013010 |
COX2 |
COII; MTCO2 |
cytochrome c oxidase subunit II |
TCMBANKGE001015 |
RAC1 |
MIG5; MRD48; Rac-1; TC-25; p21-Rac1 |
Rac family small GTPase 1 |
TCMBANKGE001008 |
CYP3A4 |
CP33; CP34; CYP3A; CYP3A3; CYPIIIA3; CYPIIIA4; HLP; NF-25; P450C3; P450PCN1 |
cytochrome P450 family 3 subfamily A member 4 |
TCMBANKGE008151 |
SPARC |
BM-40; OI17; ON; ONT |
secreted protein acidic and cysteine rich |
TCMBANKGE000526 |
ATXN1 |
ATX1; D6S504E; SCA1 |
ataxin 1 |
TCMBANKGE004494 |
CXCL14 |
BMAC; BRAK; KEC; KS1; MIP-2g; MIP2G; NJAC; SCYB14 |
C-X-C motif chemokine ligand 14 |
TCMBANKGE003699 |
GSN |
ADF; AGEL |
gelsolin |
TCMBANKGE000466 |
CYP2A6 |
CPA6; CYP2A; CYP2A3; CYPIIA6; P450C2A; P450PB |
cytochrome P450 family 2 subfamily A member 6 |
TCMBANKGE001124 |
WNT1 |
BMND16; INT1; OI15 |
Wnt family member 1 |
TCMBANKGE001156 |
CASP3 |
CPP32; CPP32B; SCA-1 |
caspase 3 |
TCMBANKGE000986 |
ERBB2 |
CD340; HER-2; HER-2/neu; HER2; MLN 19; NEU; NGL; TKR1 |
erb-b2 receptor tyrosine kinase 2 |
TCMBANKGE014353 |
ERBB3 |
ErbB-3; FERLK; HER3; LCCS2; MDA-BF-1; c-erbB-3; c-erbB3; erbB3-S; p180-ErbB3; p45-sErbB3; p85-sErbB3 |
erb-b2 receptor tyrosine kinase 3 |
TCMBANKGE013932 |
CYP4F3 |
CPF3; CYP4F; CYPIVF3; LTB4H |
cytochrome P450 family 4 subfamily F member 3 |
TCMBANKGE002108 |
CDCP1 |
CD318; SIMA135; TRASK |
CUB domain containing protein 1 |
TCMBANKGE005267 |
SETD1A |
EPEDD; KMT2F; Set1; Set1A |
SET domain containing 1A, histone lysine methyltransferase |
TCMBANKGE004699 |
EBI3 |
IL-27B; IL27B; IL35B |
Epstein-Barr virus induced 3 |
TCMBANKGE001126 |
NFE2L2 |
HEBP1; IMDDHH; NRF2; Nrf-2 |
nuclear factor, erythroid 2 like 2 |
TCMBANKGE000455 |
CYP2A13 |
CPAD; CYP2A; CYPIIA13 |
cytochrome P450 family 2 subfamily A member 13 |
TCMBANKGE008385 |
MAP3K8 |
AURA2; COT; EST; ESTF; MEKK8; TPL2; Tpl-2; c-COT |
mitogen-activated protein kinase kinase kinase 8 |
TCMBANKGE014905 |
RALBP1 |
RIP1; RLIP1; RLIP76 |
ralA binding protein 1 |
TCMBANKGE015151 |
HPGDS |
GSTS; GSTS1; GSTS1-1; PGD2; PGDS |
hematopoietic prostaglandin D synthase |
TCMBANKGE014975 |
PTAFR |
PAFR |
platelet activating factor receptor |
TCMBANKGE002198 |
DEK |
D6S231E |
DEK proto-oncogene |
TCMBANKGE010121 |
PPIG |
CARS-Cyp; CYP; SCAF10; SRCyp |
peptidylprolyl isomerase G |
TCMBANKGE001073 |
PTGS2 |
COX-2; COX2; GRIPGHS; PGG/HS; PGHS-2; PHS-2; hCox-2 |
prostaglandin-endoperoxide synthase 2 |
TCMBANKGE000728 |
MGMT |
- |
O-6-methylguanine-DNA methyltransferase |
TCMBANKGE001007 |
NR1I2 |
BXR; ONR1; PAR; PAR1; PAR2; PARq; PRR; PXR; SAR; SXR |
nuclear receptor subfamily 1 group I member 2 |
TCMBANKGE006557 |
RIPK4 |
ANKK2; ANKRD3; CHANDS; DIK; NKRD3; PKK; PPS2; RIP4 |
receptor interacting serine/threonine kinase 4 |
TCMBANKGE001141 |
PPARA |
NR1C1; PPAR; PPARalpha; hPPAR |
peroxisome proliferator activated receptor alpha |
TCMBANKGE009504 |
SND1 |
TDRD11; Tudor-SN; p100 |
staphylococcal nuclease and tudor domain containing 1 |
TCMBANKGE002615 |
PLB1 |
PLB; PLB/LIP |
phospholipase B1 |
TCMBANKGE000200 |
CYP1B1 |
ASGD6; CP1B; CYPIB1; GLC3A; P4501B1 |
cytochrome P450 family 1 subfamily B member 1 |
TCMBANKGE013318 |
PLA2G1B |
PLA2; PLA2A; PPLA2 |
phospholipase A2 group IB |
TCMBANKGE000823 |
GABPA |
E4TF1-60; E4TF1A; NFT2; NRF2; NRF2A; RCH04A07 |
GA binding protein transcription factor subunit alpha |
TCMBANKGE013769 |
SLIT2 |
SLIL3; Slit-2 |
slit guidance ligand 2 |
TCMBANKGE006643 |
YWHAZ |
14-3-3-zeta; HEL-S-3; HEL-S-93; HEL4; KCIP-1; POPCHAS; YWHAD |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta |
TCMBANKGE015090 |
CYP1A2 |
CP12; CYPIA2; P3-450; P450(PA) |
cytochrome P450 family 1 subfamily A member 2 |
TCMBANKGE008990 |
MCM7 |
CDC47; MCM2; P1.1-MCM3; P1CDC47; P85MCM; PNAS146; PPP1R104 |
minichromosome maintenance complex component 7 |
TCMBANKGE000290 |
NQO1 |
DHQU; DIA4; DTD; NMOR1; NMORI; QR1 |
NAD(P)H quinone dehydrogenase 1 |
TCMBANKGE010277 |
CYP2D6 |
CPD6; CYP2D; CYP2D7AP; CYP2D7BP; CYP2D7P2; CYP2D8P2; CYP2DL1; CYPIID6; P450-DB1; P450C2D; P450DB1 |
cytochrome P450 family 2 subfamily D member 6 |
TCMBANKGE001189 |
IL1A |
IL-1 alpha; IL-1A; IL1; IL1-ALPHA; IL1F1 |
interleukin 1 alpha |
TCMBANKGE007543 |
INSR |
CD220; HHF5 |
insulin receptor |
TCMBANKGE001102 |
MIR21 |
MIRN21; hsa-mir-21; miR-21; miRNA21 |
microRNA 21 |
TCMBANKGE005781 |
CBR1 |
CBR; SDR21C1; hCBR1 |
carbonyl reductase 1 |
TCMBANKGE000223 |
KEAP1 |
INrf2; KLHL19 |
kelch like ECH associated protein 1 |
TCMBANKGE000330 |
HMOX1 |
HMOX1D; HO-1; HSP32; bK286B10 |
heme oxygenase 1 |
TCMBANKGE000794 |
NANOG |
- |
Nanog homeobox |
TCMBANKGE000460 |
CYP2A7 |
CPA7; CPAD; CYP2A; CYPIIA7; P450-IIA4 |
cytochrome P450 family 2 subfamily A member 7 |
TCMBANKGE001080 |
AHR |
RP85; bHLHe76 |
aryl hydrocarbon receptor |
TCMBANKGE004637 |
IL18R1 |
CD218a; CDw218a; IL-18R-alpha; IL-18Ralpha; IL-1Rrp; IL18RA; IL18Ralpha2; IL1RRP |
interleukin 18 receptor 1 |
TCMBANKGE007414 |
KLKB1 |
KLK3; PKK; PKKD; PPK |
kallikrein B1 |
TCMBANKGE011976 |
CLDN16 |
HOMG3; PCLN1 |
claudin 16 |
TCMBANKGE000946 |
RAD51 |
BRCC5; FANCR; HRAD51; HsRad51; HsT16930; MRMV2; RAD51A; RECA |
RAD51 recombinase |
TCMBANKGE007559 |
SRF |
MCM1 |
serum response factor |
TCMBANKGE000639 |
HRAS |
C-BAS/HAS; C-H-RAS; C-HA-RAS1; CTLO; H-RASIDX; HAMSV; HRAS1; RASH1; p21ras |
HRas proto-oncogene, GTPase |